RAPP Rapport Therapeutics, Inc. - Common Stock
$35.67
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$8–$42
81% of range
Analyst Rating
BUY
17 analysts
Price Target
$55
+53% upside
P/E (TTM)
-10.6
ROE
-29.8%
Net Profit Margin
—
RAPP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$35.67
Market Cap
$1.45B
P/E (TTM)
-10.6
EPS (TTM)
$-2.86
Revenue (TTM)
—
Div Yield
—
ROE
-29.8%
Debt/Equity
—
52W Range
$8 – $42
RAPP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-2.86
2023-12-31
→
2025-12-31
Free Cash Flow
$-88M
2024-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
RAPP
Peer Median
P/E (TTM)
-10.6
22.4
P/B
3.0
3.7
Price / FCF
-16.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
RAPP
Peer Median
ROA
-27.0%
-9.3%
ROE
-29.8%
-4.2%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
RAPP
Peer Median
Current Ratio
26.2
9.6
Quick Ratio
25.8
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
RAPP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
RAPP
Peer Median
RAPP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
17 analysts
- Strong Buy 6 35.3%
- Buy 10 58.8%
- Hold 1 5.9%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
10 analysts · 2026-05-18
Median
$52.00
← Below all targets
$35.67
Low
$40.00
High
$80.00
Median target
$52.00
+45.8%
Mean target
$54.70
+53.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.10%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.42 | $-0.68 | 0.26% |
| Dec. 31, 2025 | $-0.72 | $-0.69 | -0.03% |
| Sept. 30, 2025 | $-0.71 | $-0.79 | 0.08% |
| June 30, 2025 | $-0.75 | $-0.85 | 0.10% |
| March 31, 2025 | $-0.68 | $-0.78 | 0.10% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| RAPP | $1.45B | -10.6 | — | — | -29.8% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | — |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $95M | $61M | $28M | |
| SG&A Expense | $30M | $22M | $8M | |
| Operating Expenses | $125M | $83M | $36M | |
| Operating Income | $-125M | $-83M | $-36M | |
| Interest Income | $14M | $12M | $3M | |
| Other Non-op | $14M | $5M | $1M | |
| Pretax Income | · | $-78M | $-35M | |
| Income Tax | $0 | $0 | $10.0K | |
| Net Income | $-111M | $-78M | $-35M | |
| EPS (Basic) | $-2.86 | $-3.78 | $-23.10 | |
| EPS (Diluted) | $-2.86 | $-3.78 | $-23.10 | |
| Shares (Basic) | 38,934,569 | 20,738,338 | 1,505,774 | |
| Shares (Diluted) | 38,934,569 | 20,738,338 | 1,505,774 | |
| EBITDA | $-124M | $-82M | · |
Balance Sheet 21
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $53M | $57M | $70M | |
| Short-term Investments | $438M | $248M | $77M | |
| Receivables | $0 | · | · | |
| Prepaid Expense | $8M | $4M | $3M | |
| Current Assets | $499M | $310M | $151M | |
| PP&E (Net) | $3M | $4M | $2M | |
| PP&E (Gross) | $5M | $4M | $2M | |
| Accum. Depreciation | $2M | $965.0K | $127.0K | |
| Other Non-current Assets | $985.0K | $160.0K | $551.0K | |
| Total Assets | $512M | $315M | $155M | |
| Accounts Payable | $4M | $2M | $3M | |
| Accrued Liabilities | $12M | $6M | $6M | |
| Current Liabilities | $19M | $9M | $9M | |
| Capital Leases | $9M | $739.0K | $1M | |
| Total Liabilities | $28M | $10M | $14M | |
| Common Stock | $48.0K | $37.0K | $4.0K | |
| Retained Earnings | $-235M | $-124M | $-45M | |
| AOCI | $546.0K | $-522.0K | $4.0K | |
| Stockholders' Equity | $485M | $305M | $-26M | |
| Liabilities + Equity | $512M | $315M | $155M | |
| Shares Outstanding | 47,772,567 | 36,580,202 | 4,170,817 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $839.0K | $112.0K | |
| Stock-based Comp | $19M | $10M | $4M | |
| Other Non-cash | $4M | $2M | · | |
| Operating Cash Flow | $-87M | $-65M | $-27M | |
| CapEx | $616.0K | $2M | $2M | |
| Investing Cash Flow | $-187M | $-170M | $-79M | |
| Stock Issued | · | · | $54.0K | |
| Financing Cash Flow | $271M | $222M | $145M | |
| Net Change in Cash | $-4M | $-13M | $39M | |
| Free Cash Flow | $-88M | $-67M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -27.0% | -33.3% | · | |
| ROE | -29.8% | -24.9% | · | |
| ROIC | · | -27.2% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 26.2 | 35.3 | · | |
| Quick Ratio | 25.8 | 34.8 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-111M | $-78M | · | |
| Market Cap | $1.45B | $649M | · | |
| P/E | -10.6 | -4.7 | · | |
| P/B | 3.0 | 2.1 | · | |
| P / Tangible Book | 3.0 | 2.1 | · | |
| P / Cash Flow | -16.6 | -10.0 | · | |
| P / FCF | -16.5 | -9.7 | · | |
| Earnings Yield | -9.4% | -21.3% | · |
Income Statement 13
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $20M | · | · | · | $0 | |
| R&D Expense | $33M | $30M | $22M | $23M | $20M | |
| SG&A Expense | $11M | $8M | $8M | $7M | $8M | |
| Operating Expenses | $44M | $39M | $30M | $29M | $27M | |
| Operating Income | $-24M | $-39M | $-30M | $-29M | $-27M | |
| Interest Income | $4M | $5M | $3M | $3M | $3M | |
| Other Non-op | $4M | $5M | $3M | $3M | $3M | |
| Net Income | $-20M | $-34M | $-27M | $-27M | $-24M | |
| EPS (Basic) | $-0.42 | $-0.72 | $-0.71 | $-0.75 | $-0.68 | |
| EPS (Diluted) | $-0.42 | $-0.72 | $-0.71 | $-0.75 | $-0.68 | |
| Shares (Basic) | 47,236,618 | -69,707,813 | 37,931,170 | 35,444,635 | 35,266,577 | |
| Shares (Diluted) | 47,236,618 | -69,707,813 | 37,931,170 | 35,444,635 | 35,266,577 | |
| EBITDA | $-24M | · | $-30M | $-29M | $-27M |
Balance Sheet 21
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $53M | $251M | $55M | $58M | |
| Short-term Investments | $399M | $438M | $262M | $205M | $228M | |
| Receivables | $58.0K | · | · | · | · | |
| Prepaid Expense | $8M | $8M | $8M | $10M | $5M | |
| Current Assets | $485M | $499M | $521M | $270M | $291M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $4M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $1M | |
| Other Non-current Assets | $1M | $985.0K | $1M | $1M | $211.0K | |
| Total Assets | $498M | $512M | $535M | $285M | $302M | |
| Accounts Payable | $7M | $4M | $3M | $3M | $2M | |
| Accrued Liabilities | $9M | $12M | $9M | $7M | $6M | |
| Current Liabilities | $18M | $19M | $14M | $12M | $9M | |
| Capital Leases | $8M | $9M | $9M | $10M | $7M | |
| Total Liabilities | $26M | $28M | $24M | $22M | $16M | |
| Common Stock | $48.0K | $48.0K | $48.0K | $37.0K | $37.0K | |
| Retained Earnings | $-255M | $-235M | $-201M | $-175M | $-148M | |
| AOCI | $-505.0K | $546.0K | $145.0K | $-76.0K | $-95.0K | |
| Stockholders' Equity | $472M | $485M | $512M | $264M | $286M | |
| Liabilities + Equity | $498M | $512M | $535M | $285M | $302M | |
| Shares Outstanding | 47,807,453 | 47,772,567 | 47,650,216 | 36,497,677 | 36,497,434 |
Cash Flow 9
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | $227.0K | $265.0K | $256.0K | $252.0K | $244.0K | |
| Stock-based Comp | $7M | $6M | $5M | $4M | $4M | |
| Other Non-cash | $-394.0K | · | · | · | $-458.0K | |
| Operating Cash Flow | $-13M | $-25M | $-17M | $-25M | $-20M | |
| CapEx | $86.0K | $169.0K | $134.0K | $22.0K | $291.0K | |
| Investing Cash Flow | $38M | $-174M | $-57M | $23M | $21M | |
| Financing Cash Flow | $531.0K | $311.0K | $271M | $-63.0K | $5.0K | |
| Net Change in Cash | $25M | $-199M | $196M | $-3M | $799.0K | |
| Free Cash Flow | $-13M | · | · | · | $-21M |
Profitability 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -121.1% | · | · | · | · | |
| Net Margin | -99.3% | · | · | · | · | |
| EBITDA Margin | -119.9% | · | · | · | · | |
| ROA | -5.0% | · | -6.2% | -8.5% | -15.9% | |
| ROE | -5.2% | · | -6.5% | -8.9% | -16.8% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 27.1 | · | 36.4 | 22.7 | 31.0 | |
| Quick Ratio | 26.6 | · | 35.8 | 21.9 | 30.4 |
Efficiency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | · | · | |
| Receivables Turnover | 689.7 | · | · | · | · |
Valuation (TTM) 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-98M | · | $-95M | $-86M | $-82M | |
| Market Cap | $1.50B | · | $1.42B | $415M | $366M | |
| P/E | -12.2 | · | -11.2 | -3.1 | -0.7 | |
| P/B | 3.2 | · | 2.8 | 1.6 | 1.3 | |
| P / Tangible Book | 3.2 | · | 2.8 | 1.6 | 1.3 | |
| P / Cash Flow | -114.5 | · | · | · | -18.1 | |
| P / FCF | -113.8 | · | · | · | -17.8 | |
| Earnings Yield | -8.2% | · | -8.9% | -31.9% | -139.1% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Net Income | $-111M | $-78M | $-35M |
| Diluted EPS | $-2.86 | $-3.78 | $-23.10 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 26.2 | 35.3 | — |
| Quick Ratio | 25.8 | 34.8 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-88M | $-67M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.